Catalyst Wire Dossier Catalyst Wire Dossier

Fast-acting Insulin Aspart

insulin aspart · Novo Nordisk A/S
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Fast-acting Insulin Aspart, covering 2020-03-12 to 2024-03-20. Get the full timeline:

Most recent: Clinical Trial Update: Research Study to Compare a New Medicine "Fast-acting Insulin Aspart" to Another Medicine "Insulin Aspart" in Chinese People With Diabetes [Phase 3]

See pricing